Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hong Liu (H Liu)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Venues

Nature communications

Journal of medical Internet research

Journal of cellular and molecular medicine

Journal of the European Academy of Dermatology and Venereology : JEADV

Xiangya Hospital, Central South University

University of Texas Health Science Center at Houston (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Xiangya Hospital, Central South University

China

Research Professor

Education History

University of Texas Health Science Center at Houston Aug 13o 2012

United States

PHD :: Biochemistry and Molecular Biology

Publications

Yu Dong, Qian Gao, Yong Chen, Zhao Zhang, Yanhua Du, Yuan Liu, Guangxiong Zhang, Shengli Li, Gaoyang Wang, Xiang Chen, Hong Liu, Leng Han, Youqiong Ye
Identification of CircRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy. Nature communications 14 (1) (2023)
Yu Dong, Qian Gao, Yong Chen, Zhao Zhang, Yanhua Du, Yuan Liu, Guangxiong Zhang, Shengli Li, Gaoyang Wang, Xiang Chen, Hong Liu, Leng Han, Youqiong Ye
Identification of CircRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy. Nature communications 14 (1) (2023)
Yu Dong, Qian Gao, Yong Chen, Zhao Zhang, Yanhua Du, Yuan Liu, Guangxiong Zhang, Shengli Li, Gaoyang Wang, Xiang Chen, Hong Liu, Leng Han, Youqiong Ye
Identification of CircRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy. Nature communications 14 (1) (2023)
Yu Dong, Qian Gao, Yong Chen, Zhao Zhang, Yanhua Du, Yuan Liu, Guangxiong Zhang, Shengli Li, Gaoyang Wang, Xiang Chen, Hong Liu, Leng Han, Youqiong Ye
Identification of CircRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy. Nature communications 14 (1) (2023)
Yantao Xu, Zixi Jiang, Xinwei Kuang, Xiang Chen, Hong Liu
Research Trends in Immune Checkpoint Blockade for Melanoma: Visualization and Bibliometric Analysis. Journal of medical Internet research 24 (6) (2022)
Han Gong, Heng Li, Qin Yang, Guangxiong Zhang, Hong Liu, Zekang Ma, Hong-Ling Peng, Ling Nie, Xiaojuan Xiao, Jing Liu
A Ferroptosis Molecular Subtype-Related Signature for Predicting Prognosis and Response to Chemotherapy in Patients with Chronic Lymphocytic Leukemia. BioMed research international 2022 (2022)
Mei Luo, Lin Ye, Ruimin Chang, Youqiong Ye, Zhao Zhang, Chun-Jie Liu, Shengli Li, Ying Jing, Hang Ruan, Guanxiong Zhang, Yi He, Yaoming Liu, Yu Xue, Xiang Chen, An-Yuan Guo, Hong Liu, Leng Han
Multi-omics characterization of autophagy-related molecular features for therapeutic targeting of autophagy. Nature communications 13 (1) (2022)
P Lau, Minxue Shen, F Ma, Y Chen, J Zhang, Juan Su, X Chen, Hong Liu
A Bayesian network meta-analysis of comparison of cancer therapeutic vaccines for melanoma. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (10) (2021)
Jia Guo, JiangLing Zhang, Long Liang, Nian Liu, Min Qi, Shuang Zhao, Juan Su, Jing Liu, Cong Peng, Xiang Chen, Hong Liu
Potent USP10/13 antagonist spautin-1 suppresses melanoma growth via ROS-mediated DNA damage and exhibits synergy with cisplatin. Journal of cellular and molecular medicine 24 (7) (2020)
Youqiong Ye, Ying Jing, Liang Li, Gordon B Mills, Lixia Diao, Hong Liu, Leng Han
Sex-associated molecular differences for cancer immunotherapy. Nature communications 11 (1) (2020)

Hong Liu.css-eqlu8i{font-size:small;padding-left:4px;} (H Liu)

Publication Activity (10 Years)

Top Topics

Top Venues

Hong Liu (H Liu)